ANXA2 and hepatocellular carcinoma: We measured ANXA2 expression in HCC cell lines and found that ANXA2 expression was higher in HCC cell lines with high metastatic potential (MHCC97L, MHCC97H, and HCCLM3) than in cell lines with low metastatic potential (Hep3B, PLC/PRF/5, Huh7, and HepG2; Figure 6F).